StreetAlpha
Enanta Pharmaceuticals Inc · SEC Form 4

ENTA Insider Trading

From SEC Form 416 trades in 2 yearsUpdated Nov 21, 2026

Every open market buy and sale of Enanta Pharmaceuticals Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $183K sold.

← ENTA stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$183K9 sales · 7 insiders
Net−$183Kbought minus sold
Planned sales–of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: sold $183KDecJanFebMarAprMayJunJulAugSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when ENTA insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an ENTA officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every ENTA insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Dec 5, 2025Jay R. LulyPresident and CEOSale4,743$14.23$67K858,026Dec 5Form 4
Dec 5, 2025Yat Sun OrChief Scientific OfficerSale2,390$14.23$34K371,392Dec 5Form 4
Dec 5, 2025Tara Lynn KiefferChief Product Strategy OfficerSale2,106$14.23$30K30,620Dec 5Form 4
Dec 5, 2025Brendan LuuChief Business OfficerSale1,394$14.23$20K38,329Dec 5Form 4
Dec 5, 2025Scott T. RottinghausChief Medical OfficerSale798$14.23$11K21,792Dec 5Form 4
Dec 5, 2025Harry R. Trout IIISee RemarksSale542$14.23$8K16,348Dec 5Form 4
Dec 5, 2025Kathleen S. CappsSee RemarksSale323$14.23$5K8,377Dec 5Form 4
Dec 2, 2025Harry R. Trout IIISee RemarksSale380$13.96$5K16,890Dec 3Form 4
Dec 2, 2025Kathleen S. CappsSee RemarksSale207$13.96$3K8,700Dec 3Form 4
Feb 12, 2025Jay R. LulyPresident and CEOBuy45,000$5.69$256K846,638Feb 12Form 4
Dec 6, 2024Jay R. LulyPresident and CEOSale plan5,142$8.06$41K801,638Dec 10Form 4
Dec 6, 2024Paul J MellettChief Fin. & Admin OfficerSale plan2,591$8.06$21K91,710Dec 10Form 4
Dec 6, 2024Yat Sun OrChief Scientific OfficerSale plan2,591$8.06$21K369,109Dec 10Form 4
Dec 6, 2024Scott T. RottinghausChief Medical OfficerSale plan866$8.06$7K17,918Dec 10Form 4
Dec 6, 2024Brendan LuuChief Business OfficerSale plan2,283$8.06$18K36,047Dec 10Form 4
🔒 1 more trades. Create a free account or sign in to see them all.

ENTA insider trading FAQ

Are ENTA insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of ENTA on the open market in 0 trades, and 7 sold $183K in 9 trades.

When did an ENTA insider last buy shares?

Jay R. Luly (President and CEO) bought 45,000 shares for $256K on Feb 12, 2025, reported on Feb 12, 2025.

When did an ENTA insider last sell shares?

Jay R. Luly (President and CEO) sold 4,743 shares for $67K on Dec 5, 2025.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice